Literature DB >> 20102225

Identification of bZIP interaction partners of viral proteins HBZ, MEQ, BZLF1, and K-bZIP using coiled-coil arrays.

Aaron W Reinke1, Gevorg Grigoryan, Amy E Keating.   

Abstract

Basic-region leucine-zipper transcription factors (bZIPs) contain a segment rich in basic amino acids that can bind DNA, followed by a leucine zipper that can interact with other leucine zippers to form coiled-coil homo- or heterodimers. Several viruses encode proteins containing bZIP domains, including four that encode bZIPs lacking significant homology to any human protein. We investigated the interaction specificity of these four viral bZIPs by using coiled-coil arrays to assess self-associations as well as heterointeractions with 33 representative human bZIPs. The arrays recapitulated reported viral-human interactions and also uncovered new associations. MEQ and HBZ interacted with multiple human partners and had unique interaction profiles compared to any human bZIPs, whereas K-bZIP and BZLF1 displayed homospecificity. New interactions detected included HBZ with MAFB, MAFG, ATF2, CEBPG, and CREBZF and MEQ with NFIL3. These were confirmed in solution using circular dichroism. HBZ can heteroassociate with MAFB and MAFG in the presence of MARE-site DNA, and this interaction is dependent on the basic region of HBZ. NFIL3 and MEQ have different yet overlapping DNA-binding specificities and can form a heterocomplex with DNA. Computational design considering both affinity for MEQ and specificity with respect to other undesired bZIP-type interactions was used to generate a MEQ dimerization inhibitor. This peptide, anti-MEQ, bound MEQ both stably and specifically, as assayed using coiled-coil arrays and circular dichroism in solution. Anti-MEQ also inhibited MEQ binding to DNA. These studies can guide further investigation of the function of viral and human bZIP complexes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20102225      PMCID: PMC2841013          DOI: 10.1021/bi902065k

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  71 in total

1.  A comprehensive analysis of recruitment and transactivation potential of K-Rta and K-bZIP during reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  Thomas J Ellison; Yoshihiro Izumiya; Chie Izumiya; Paul A Luciw; Hsing-Jien Kung
Journal:  Virology       Date:  2009-03-09       Impact factor: 3.616

2.  A synthetic coiled-coil interactome provides heterospecific modules for molecular engineering.

Authors:  Aaron W Reinke; Robert A Grant; Amy E Keating
Journal:  J Am Chem Soc       Date:  2010-05-05       Impact factor: 15.419

3.  Homodimerization of the Meq viral oncoprotein is necessary for induction of T-cell lymphoma by Marek's disease virus.

Authors:  Andrew C Brown; Lorraine P Smith; Lydia Kgosana; Susan J Baigent; Venugopal Nair; Martin J Allday
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

4.  The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity.

Authors:  Jihane Basbous; Charlotte Arpin; Gilles Gaudray; Marc Piechaczyk; Christian Devaux; Jean-Michel Mesnard
Journal:  J Biol Chem       Date:  2003-08-22       Impact factor: 5.157

5.  Homodimerization of Marek's disease virus-encoded Meq protein is not sufficient for transformation of lymphocytes in chickens.

Authors:  Paulette F Suchodolski; Yoshihiro Izumiya; Blanca Lupiani; Dharani K Ajithdoss; Oren Gilad; Lucy F Lee; Hsing-Jien Kung; Sanjay M Reddy
Journal:  J Virol       Date:  2008-10-29       Impact factor: 5.103

6.  Characterization of the chromosomal binding sites and dimerization partners of the viral oncoprotein Meq in Marek's disease virus-transformed T cells.

Authors:  Alon M Levy; Yoshihiro Izumiya; Peter Brunovskis; Liang Xia; Mark S Parcells; Sanjay M Reddy; Lucy Lee; Hong-Wu Chen; Hsing-Jien Kung
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

7.  Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands.

Authors:  M Kvansakul; H Yang; W D Fairlie; P E Czabotar; S F Fischer; M A Perugini; D C S Huang; P M Colman
Journal:  Cell Death Differ       Date:  2008-06-13       Impact factor: 15.828

8.  HBZ interacts with JunD and stimulates its transcriptional activity.

Authors:  Sabine Thébault; Jihane Basbous; Patrick Hivin; Christian Devaux; Jean-Michel Mesnard
Journal:  FEBS Lett       Date:  2004-03-26       Impact factor: 4.124

9.  Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 K-bZIP modulates latency-associated nuclear protein-mediated suppression of lytic origin-dependent DNA synthesis.

Authors:  Cyprian Rossetto; Irena Yamboliev; Gregory S Pari
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

10.  Design of protein-interaction specificity gives selective bZIP-binding peptides.

Authors:  Gevorg Grigoryan; Aaron W Reinke; Amy E Keating
Journal:  Nature       Date:  2009-04-16       Impact factor: 49.962

View more
  33 in total

Review 1.  Protein binding specificity versus promiscuity.

Authors:  Gideon Schreiber; Amy E Keating
Journal:  Curr Opin Struct Biol       Date:  2010-11-09       Impact factor: 6.809

2.  HBZ-mediated shift of JunD from growth suppressor to tumor promoter in leukemic cells by inhibition of ribosomal protein S25 expression.

Authors:  M Terol; H Gazon; I Lemasson; M Duc-Dodon; B Barbeau; R Césaire; J-M Mesnard; J-M Péloponèse
Journal:  Leukemia       Date:  2017-03-06       Impact factor: 11.528

3.  HTLV-1 HBZ protein deregulates interactions between cellular factors and the KIX domain of p300/CBP.

Authors:  Pamela R Cook; Nicholas Polakowski; Isabelle Lemasson
Journal:  J Mol Biol       Date:  2011-04-08       Impact factor: 5.469

Review 4.  Designing specific protein-protein interactions using computation, experimental library screening, or integrated methods.

Authors:  T Scott Chen; Amy E Keating
Journal:  Protein Sci       Date:  2012-06-08       Impact factor: 6.725

5.  Design of peptide inhibitors that bind the bZIP domain of Epstein-Barr virus protein BZLF1.

Authors:  T Scott Chen; Aaron W Reinke; Amy E Keating
Journal:  J Mol Biol       Date:  2011-02-25       Impact factor: 5.469

6.  Increasing the affinity of selective bZIP-binding peptides through surface residue redesign.

Authors:  Jenifer B Kaplan; Aaron W Reinke; Amy E Keating
Journal:  Protein Sci       Date:  2014-04-30       Impact factor: 6.725

7.  A leucine zipper motif of a tegument protein triggers final envelopment of human cytomegalovirus.

Authors:  Christina Sylvia Meissner; Sascha Suffner; Martin Schauflinger; Jens von Einem; Elke Bogner
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

8.  Expression of a protein involved in bone resorption, Dkk1, is activated by HTLV-1 bZIP factor through its activation domain.

Authors:  Nicholas Polakowski; Heather Gregory; Jean-Michel Mesnard; Isabelle Lemasson
Journal:  Retrovirology       Date:  2010-07-23       Impact factor: 4.602

Review 9.  Designing helical peptide inhibitors of protein-protein interactions.

Authors:  Raheleh Rezaei Araghi; Amy E Keating
Journal:  Curr Opin Struct Biol       Date:  2016-04-25       Impact factor: 6.809

10.  The Human T-Cell Leukemia Virus Type 1 Basic Leucine Zipper Factor Attenuates Repair of Double-Stranded DNA Breaks via Nonhomologous End Joining.

Authors:  Amanda W Rushing; Kimson Hoang; Nicholas Polakowski; Isabelle Lemasson
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.